e-Therapeutics plc announced the appointment of Christine Soden as non-executive director, and the retirement of Brad Hoy who has served on the e-Therapeutics Board as a non-executive director for nine years. Christine will take over from Brad Hoy as Chair of the Board's Audit & Risk Committee. Currently Christine is CFO at Acacia Pharma Group Limited and is a non-executive director at two private biotech companies.